Two randomized phase III clinical trials evaluating anti-inflammatory dose doxycycline (40 mg doxycycline, USP capsules) administered once daily for treatment of rosacea - Del Rosso, J Q; Webster, G F; Jackson, M (J Am Acad Dermatol, 2007)
et al.